Drug information is subject to change and may not cover all uses, directions, precautions, warnings, interactions, reactions, or adverse effects
Once-weekly injections for proven, sustainable weight loss
The specific marketing claims CrazyLeaf advertises the following benefits for their SMGT-GLP-1 patch: "Painless alternative to Ozempic injections" "Fast fat burning capability" Appetite suppression comparable to prescription medications Blood glucose stabilization "Clinically proven and certified by national authorities" Used by "over 2.25 million people" That last claim is particularly telling
10.1111/dom.13856 42 KellererM.KaltoftM
With anticipation of aleniglipron being a strong contender in the still-emergent GLP-1 pill space, investors who take a chance on GPCR shares may be rewarded with a bump when new results do become available, although this is, of course, a risk